F-group (family)
10.2.1.1 Rhv
Ligands and drugs
2,066
Member domains
275
with ligand contacts (≤ 4 Å)
13.3% of members
332
with DrugDomain annotations
16.1% of members
197
with a DrugBank compound
9.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 10.2.1.1 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 63 |
| DB08231 | MYR | Myristic acid | 33 |
| DB05105 | W11 | Pleconaril | 10 |
| DB02210 | HEZ | Hexane-1,6-Diol | 9 |
| DB08726 | W71 | Disoxaril | 7 |
| DB00143 | GSH | Glutathione | 6 |
| DB08013 | J78 | (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE | 6 |
| DB03017 | DAO | Lauric acid | 5 |
| DB03193 | STE | Stearic acid | 5 |
| DB03685 | U | Uridine monophosphate | 5 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 4 |
| DB08012 | J77 | Pirodavir | 4 |
| DB08014 | J80 | (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE | 4 |
| DB08720 | W35 | 5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole | 4 |
| DB17736 | SC4 | Pocapavir | 3 |
| DB00145 | GLY | Glycine | 2 |
| DB00151 | CYS | Cysteine | 2 |
| DB02377 | GUN | Guanine | 2 |
| DB08017 | JEN | 3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE | 2 |
| DB08723 | W54 | WIN-54954 | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SPH | SPHINGOSINE | 53 |
| PLM | PALMITIC ACID | 48 |
| CL | CHLORIDE ION | 28 |
| CAmetal | CALCIUM ION | 18 |
| MYR | MYRISTIC ACID | 18 |
| NAmetal | SODIUM ION | 15 |
| Kmetal | POTASSIUM ION | 10 |
| HEZ | HEXANE-1,6-DIOL | 9 |
| GSH | Glutathione | 8 |
| W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 7 |
| J78 | (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE | 6 |
| W11 | 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE | 6 |
| DAO | LAURIC ACID | 5 |
| STE | STEARIC ACID | 5 |
| FHK | 4-[[4-[1,3-bis(oxidanylidene)isoindol-2-yl]phenyl]sulfonylamino]benzoic acid | 4 |
| J77 | (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE | 4 |
| J80 | (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE | 4 |
| SIA | N-acetyl-alpha-neuraminic acid | 4 |
| W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE | 4 |
| W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 4 |